Novel Treatments for Drug-Induced Toxic Epidermal Necrolysis (Lyell’s Syndrome)

International Archives of Allergy and Immunology - Tập 136 Số 3 - Trang 205-216 - 2005
Philippe Paquet1, Gérald Pierard1, Pascale Quatresooz1
1Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >

Tóm tắt

Drug-induced toxic epidermal necrolysis (TEN) is a life-threatening disease characterized by extensive destruction of the epidermis. It apparently results from the formation of specific toxic drug metabolites by the keratinocytes. The mortality rate which averages 25–30% is mainly due to secondary septicemia, and to ionic and metabolic disturbances following loss of epidermal integrity. Apoptosis is the likely mechanism leading to massive keratinocyte death in TEN. Dysregulations in the tumor necrosis factor-α (TNF-α) pathway, CD95 system (Fas ligand, CD95L; Fas receptor, CD95R) and calcium homeostasis in the epidermis are involved in this apoptotic process. An active role has also been ascribed to T lymphocytes, macrophages and factor XIIIa-positive dermal dendrocytes. Despite progress, treatment of TEN remains controversial. In the past, systemic glucocorticoids were used in order to target the inflammatory reaction in TEN. However, there was no evidence for improvement of the healing process, while corticosteroids worsened the prognosis by increasing the risk of septicemia. Only a few cases have been treated with other drugs including cyclophosphamide, pentoxyfilline, thalidomide, anti-TNF-α antibodies and cyclosporin A. In the recent past, some TEN patients were treated with intravenous human immunoglobulins (IVIG). The rationale for such a treatment was to block the CD95 system on keratinocytes. The early promising clinical results of IVIG treatment in TEN were subsequently challenged. This review compares the effectiveness and drawbacks of the major drugs presently used in TEN treatment. Some future prospects in TEN management are also discussed.

Từ khóa


Tài liệu tham khảo

10.2165%2F00128071-200001060-00003

10.1111%2F1523-1747.ep12388434

10.1097%2F00000372-199704000-00005

10.1001%2Farchderm.123.9.1166

10.1056%2FNEJM199512143332404

10.1001%2Farchderm.131.5.544

10.1016%2FS0009-2797%2898%2900021-0

10.1046%2Fj.1523-1747.2000.00985.x

10.1097%2F00008571-199508000-00011

10.1111%2Fj.1600-0625.1995.tb00211.x

10.1016%2F0190-9622%2892%2970082-Q

10.1038%2Fclpt.1993.66

10.1097%2F01.all.0000011028.08297.b3

10.1001%2Farchderm.130.5.605

10.1067%2Fmjd.2002.120473

10.1111%2Fj.1600-0560.1999.tb01848.x

10.1126%2Fscience.282.5388.490

10.1016%2FS0167-5699%2897%2901202-4

10.1001%2Farchderm.129.4.466

10.1159%2F000051751

10.1046%2Fj.1365-2249.2000.01119.x

10.1097%2F00000372-200010000-00005

10.1159%2F000018108

10.1002%2F%28SICI%291097-4652%28199705%29171%3A2%3C190%3A%3AAID-JCP9%3E3.0.CO%3B2-J

10.1159%2F000069961

10.1111%2Fj.1365-2133.1996.tb06976.x

10.1159%2F000018112

10.1046%2Fj.1523-1747.2000.00816.x

10.1007%2Fs000110050313

10.1046%2Fj.1523-1747.2003.12360.x

10.1001%2Farchderm.136.3.323

10.1097%2F00003246-200211000-00029

10.1001%2Farchderm.123.9.1156

10.1542%2Fpeds.108.5.1162

10.1097%2F00004630-199909000-00013

10.1067%2Fmai.2001.118796

10.1016%2FS0006-291X%2888%2981238-5

10.1016%2F0014-5793%2890%2980161-B

10.1016%2F0006-2952%2893%2990098-H

10.1056%2FNEJM199912093412407

10.1097%2F00006534-197861060-00021

10.1111%2Fj.1365-2230.1982.tb02385.x

10.1046%2Fj.1365-4362.1997.00100.x

10.1111%2Fj.1365-2133.1993.tb00185.x

10.1159%2F000248010

10.1001%2Farchderm.131.6.669

10.1097%2F00000658-198611000-00001

10.1016%2FS0022-3476%2889%2980736-X

10.1016%2FS0022-3468%2889%2980240-4

10.1016%2F0305-4179%2890%2990165-S

10.1016%2F0305-4179%2895%2900140-9

10.1097%2F00004630-199711000-00009

10.1097%2F00004630-199909000-00002

10.1097%2F00004630-200021030-00004

10.1046%2Fj.1440-0960.1999.00347.x

10.1046%2Fj.1365-2133.2000.03265.x

10.1159%2F000051702

10.1016%2FS0305-4179%2801%2900005-5

10.1067%2Fmjd.2002.127249

10.1001%2Farchderm.139.1.26

10.1001%2Farchderm.139.1.33

10.1001%2Farchderm.139.1.39

10.1111%2Fj.1365-4362.1989.tb02502.x

10.1111%2Fj.1365-2133.1995.tb02649.x

10.1111%2Fj.1440-0960.1996.tb01057.x

10.1046%2Fj.1365-2230.1997.2190648.x

10.1046%2Fj.1365-2230.1997.1900625.x

10.1016%2FS0926-9959%2897%2900047-0

10.1097%2F00005373-200003000-00017

10.1159%2F000247481

10.1001%2Farchinte.156.11.1238

10.1046%2Fj.1365-2133.1997.d01-1994.x

10.1067%2Fmjd.2002.118557

10.1084%2Fjem.172.1.391

10.1016%2FS0006-291X%2888%2981271-3

10.1111%2Fj.1365-2133.1994.tb13130.x

10.1016%2FS0190-9622%2808%2980969-3

10.1097%2F00007611-199610000-00015

10.1046%2Fj.1365-4362.1997.00298.x

10.1006%2Fclin.1996.0181

10.1016%2FS0140-6736%2898%2902197-7

10.1006%2Fbbrc.1996.1043

10.1046%2Fj.1365-4362.1999.00566.x

10.1016%2FS0140-6736%2805%2974905-9

10.1046%2Fj.1365-2133.2002.46833.x

10.1046%2Fj.1365-2133.1996.d01-994.x

10.1159%2F000048174

10.1046%2Fj.1365-4362.1997.00192.x

10.1016%2FS0190-9622%2899%2970497-4

10.1007%2Fs001340051063

10.1046%2Fj.1365-2362.1998.00329.x

Thông tin
Thông tin xuất bản

International Archives of Allergy and Immunology

Tập 136 Số 3

205-216

Thông tin tác giả